Valproate Versus Ketorolac Versus Metoclopramide

• Status: Completed
• Trial end date: 2013-03-01
• Target enrollment: 0
• Participant gender: All

Summary

This randomized study is testing 3 different intravenous medications to see which one is best for acute migraine. The three medications are metoclopramide, valproate, and ketorolac.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Montefiore Medical Center
• Treatments: Ketorolac; Ketorolac Tromethamine; Metoclopramide; Valproic Acid

Criteria

Inclusion Criteria:

• IHS migraine without aura

• IHS probable migraine (all migraine without arua criteria must be met except duration may be >72 hours or <4 hours)

Exclusion Criteria:

• Allergy or contra-indication to investigational medication